1039 Vaccination with a single dose of a novel delivery platform confers durable greater than 8 month immune responses, with lasting protection against tumour and metastases in preclinical models
Lee LN., Kwok J., Kroon AMT., Chinnakannan S., Marinou S., ten Bokum A., Beach C., John S., Davies T., de Lara C., Hutchings C., Highton A., Parker R., Salatino S., Tong O., Ternette N., Gileadi U., Klenerman P.